Literature DB >> 6753566

Functioning oxyphil cell adenomas of parathyroid gland: immunoperoxidase evidence of hormonal activity in oxyphil cells.

N G Ordonez, M L Ibanez, B Mackay, N A Samaan, R C Hickey.   

Abstract

Functional oxyphil adenomas of parathyroid gland are rare. Several studies have suggested that these tumors consist of a mixed cell population and that the transitional oxyphil cells and/or chief cells are the main source of parathormone, while the fully developed oxyphil cells have minimal or no hormonal activity. This report describes light, ultrastructural, and immunocytochemical features of six parathyroid adenomas, and confirms that these neoplasms are composed of a mixed cell population. It also demonstrates that the oxyphil cells have strong hormonal activity and therefore can play a significant role in the pathogenesis of hyperparathyroidism.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6753566     DOI: 10.1093/ajcp/78.5.681

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  4 in total

1.  Parathyroid gastrin and parathormone-producing tumour in the Zollinger-Ellison syndrome of MEN 1 origin.

Authors:  D Santini; G Pasquinelli; L D'Alessandro; G Mazzoleni; M Taffurelli; O Campione; D Marrano; G N Martinelli
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

Review 2.  Malignant pancreatic oncocytoma. An unusual cause of organic hypoglycemia.

Authors:  J L Sadoul; M C Saint-Paul; P Hoffman; M Plazza; Y Birtwisle; P Freychet; R Loubiere
Journal:  J Endocrinol Invest       Date:  1992-03       Impact factor: 4.256

3.  Cox-2 expression in the oxyphilic cells of the normal, hyperplastic, and adenomatous parathyroid gland.

Authors:  C David Bell; Sergio Vidal; Kalman Kovacs; Jennifer Anderson; Fabio Rotondo
Journal:  Endocr Pathol       Date:  2004       Impact factor: 3.943

4.  Monocentric experience of primary hyperparathyroidism surgery in Algeria.

Authors:  Souad Nouikes Zitouni
Journal:  Surg Open Sci       Date:  2021-02-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.